BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis.

Auteurs : Willaert W, Van Der Speeten K, Liberale G, Ceelen W
Année : 2015
Journal : BMC Cancer
Volume : 15
Pages : 980